Sohag University: Carcinoma trials
The registry lists 28 Carcinoma studies with Sohag University as lead sponsor. 6 are open to participants now and 0 have results posted.
Early Phase 1 1No phase 27(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Role of Omega-6 Fatty Acids in Hepatocellular Carcinoma Development.Not yet recruitingNCT07265076
- Sialic Acid in Hepatocellular CarcinomaNot yet recruitingNCT06836518
- B-catenin in Cutaneous Squamous Cell Carcinoma and Its MimickersRecruitingNCT06536946
- Identification of Pattern and Factors Affecting Recurrence in Head and Neck CarcinomaRecruitingNCT06465030
- The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic PatientsNot yet recruitingNCT06328283
- Predictors of Sorafenib Response in HCCNot yet recruitingNCT05967429
- Moesin Expression in Clear Cell Renal Cell CarcinomaCompletedNCT06055660
- Paraneoplastic Syndrome in Hepatocellular Carcinoma PatientsStatus unknownNCT05846035
- Immunohistochemical Expression of Inhibin Beta A (INHBA) in Colorectal CarcinomaStatus unknownNCT05794737
- Diagnostic Accuracy of APAC, ASAP and GALAD Scores in Hepatocellular Carcinoma Among Cirrhotic PatientsStatus unknownNCT05738772
- ALBI and PALBI Scores and HCC PrognosisCompletedNCT05720195
- Galectin-3 in Papillary Thyroid CarcinomaStatus unknownNCT05699590
- PDL1 In Primary Colorectal Carcinoma and Its Prognostic ImpactStatus unknownNCT05692895
- Outcome of Laparoscopic Total Mesorectal Excision Versus Open Technique in Management of Rectal CarcimomaStatus unknownNCT05685680Not applicable
- Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal CarcinomaStatus unknownNCT05595265
- Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian CarcinomaStatus unknownNCT05576519
- Vitamin-D Receptor in Laryngeal Squamous Cell CarcinomaStatus unknownNCT05568641
- Serum Levels of Some Trace Elements in Hepatocellular Carcinoma PatientsStatus unknownNCT05488587
- Oncological and Functional Outcomes of Laparoscopic Partial Nephrectomy in Renal Cell Carcinoma Stages T1 Versus T2a: Prospective Comparative Study.Status unknownNCT05486871Not applicable
- SOX2 & PDL1 Expression on Urinary Bladder CarcinomaStatus unknownNCT05429710
- Expression of STEAP-1 and p40 in Prostatic Carcinoma and Its MimickersStatus unknownNCT05428319
- IMP3 and PCNA Expression in Laryngeal Squamous Cell Carcinoma in Sohag GovernorateStatus unknownNCT05293327
- Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial CarcinomaStatus unknownNCT05139134
- Role of DEB-TACE Versus c-TACE in Treatment of HCCStatus unknownNCT05093920Early Phase 1
- Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian PopulationCompletedNCT05070039Not applicable
- Significance of Immunohistochemical Expression of Survivin in Renal Cell CarcinomaCompletedNCT04873180
- Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver CirrhosisCompletedNCT04763707
- Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular CarcinomaCompletedNCT04553458